Hepatitis B Virus: From Diagnosis to Treatment

被引:52
|
作者
Guvenir, Meryem [1 ]
Arikan, Ayse [2 ,3 ]
机构
[1] Near East Univ, Vocat Sch Hlth Serv, Nicosia, Northern Cyprus, Turkey
[2] Near East Univ, Dept Med Microbiol, Fac Med, Nicosia, Northern Cyprus, Turkey
[3] Near East Univ, DESAM Inst, Nicosia, Northern Cyprus, Turkey
关键词
hepatitis B virus (HBV); serology; nucleic acid testing; antiviral treatment; TENOFOVIR ALAFENAMIDE; THERAPY; HBEAG; MUTATIONS; IDENTIFICATION; EPIDEMIOLOGY; REACTIVATION; LAMIVUDINE; INFECTION; UPDATE;
D O I
10.33073/pjm-2020-044
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis B infection is still a global concern progressing as acute-chronic hepatitis, severe liver failure, and death. The infection is most widely transmitted from the infected mother to a child, with infected blood and body fluids. Pregnant women, adolescents, and all adults at high risk of chronic infection are recommended to be screened for hepatitis B infection. The initial analysis includes serological tests that allow differentiation of acute and chronic hepatitis. Molecular assays performed provide detection and quantification of viral DNA, genotyping, drug resistance, and precore/core mutation analysis to confirm infection and monitor disease progression in chronic hepatitis B patients. All patients with chronic hepatitis B should be treated with antiviral medications and regularly monitored for efficient treatment. The current treatment Is based on nucleos(t)ide analogs and pegylated interferons that save lives by decreasing liver cancer death, liver transplant, slow or reverse the progression of liver disease as well as the virus infectivity.
引用
收藏
页码:391 / 399
页数:9
相关论文
共 50 条
  • [1] Hepatitis B virus: From diagnosis to treatment
    Deny, P.
    Zoulim, F.
    PATHOLOGIE BIOLOGIE, 2010, 58 (04): : 245 - 253
  • [2] Chronic Hepatitis B Virus: What an Internist Needs to Know Serologic Diagnosis, Treatment Options, and Hepatitis B Virus Reactivation
    Block, Peter D.
    Lim, Joseph K.
    MEDICAL CLINICS OF NORTH AMERICA, 2023, 107 (03) : 435 - 447
  • [3] Is response to antiviral treatment influenced by hepatitis B virus genotype?
    Raimondi, Sara
    Maisonneuve, Patrick
    Bruno, Savino
    Mondelli, Mario U.
    JOURNAL OF HEPATOLOGY, 2010, 52 (03) : 441 - 449
  • [4] Treatment of Hepatitis B Virus Cirrhosis
    Rizzetto, Mario
    HEPATITIS MONTHLY, 2012, 12 (05) : 309 - 311
  • [5] Individual prediction model for lamivudine treatment response in hepatitis B virus e antigen-positive chronic hepatitis B patients
    Lee, Hyun Woong
    Kang, Wonseok
    Ahn, Sang Hoon
    Lee, Heon Ju
    Hwang, Jae Seok
    Sohn, Joo Hyun
    Jang, Jae Young
    Han, Ki Jun
    Kim, Ja Kyung
    Kim, Do Young
    Paik, Yong Han
    Lee, Chun Kyon
    Choi, Ik-Seong
    Lee, Kwan Sik
    Han, Kwang-Hyub
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (05) : 1049 - 1055
  • [6] Hepatitis B virus genotyping among chronic hepatitis B patients with resistance to treatment with lamivudine in the City of Ribeirao Preto, State of Sao Paulo
    Haddad, Rodrigo
    Candolo Martinelli, Ana de Lourdes
    Uyemura, Sergio Akira
    Yokosawa, Jonny
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2010, 43 (03) : 224 - 228
  • [7] New drugs for the treatment of chronic hepatitis B and interdisciplinary aspects of chronic hepatitis B virus infection
    Horvath, Gabor
    ORVOSI HETILAP, 2013, 154 (29) : 1142 - 1150
  • [8] Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis
    Inada, Kento
    Kaneko, Shun
    Kurosaki, Masayuki
    Yamashita, Koji
    Kirino, Sakura
    Osawa, Leona
    Hayakawa, Yuka
    Sekiguchi, Shuhei
    Higuchi, Mayu
    Takaura, Kenta
    Maeyashiki, Chiaki
    Tamaki, Nobuharu
    Yasui, Yutaka
    Itakura, Jun
    Takahashi, Yuka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Okamoto, Ryuichi
    Izumi, Namiki
    JGH OPEN, 2021, 5 (09): : 1085 - 1091
  • [9] Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
    Shalaby, El-Araby Mohamed Ibrahim
    Abdelsameea, Eman
    Naguib, Mary
    Gomaa, Asmaa
    Waked, Imam
    EGYPTIAN LIVER JOURNAL, 2023, 13 (01)
  • [10] Molecular diagnosis and treatment of drug-resistant hepatitis B virus
    Jeong Han Kim
    Yong Kwang Park
    Eun-Sook Park
    Kyun-Hwan Kim
    World Journal of Gastroenterology, 2014, (19) : 5708 - 5720